Protective effects of fisetin on ovarian ischemia-reperfusion injury in rats via modulation of the TLR4-MyD88-TRAF6 signaling pathway
Acta Cirúrgica Brasileira · 2025 · 40
DOI: 10.1590/acb405925 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Cirúrgica Brasileira, 2025. Verfasst von Qianqian Gao und 2 weiteren Autor:innen. Beteiligte Einrichtung: China Three Gorges University - The First College of Clinical Medical Science - Yichang - China. Hauptthemen laut MEDLINE: Signal Transduction, Toll-Like Receptor 4, Reperfusion Injury, Myeloid Differentiation Factor 88. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Hubei Province.
Abstract (Originalsprache)
Purpose
To investigate the protective effects of fisetin on ovarian ischemia-reperfusion injury in rats, focusing on the modulation of the TLR4-MyD88-TRAF6 signaling pathway.
Methods
Wistar rats randomly divided into different groups received oral administration of fisetin (5, 10 and 15 mg/kg). Body weight and ovary weight were measured. Hormones, hematological, antioxidant, cytokines, inflammatory and apoptosis parameters were assessed. Histological and histopathologic evaluations were conducted on ovary tissue. Different mRNA expressions were estimated.
Results
Dose dependent treatment significantly improved body and ovary weight along with alteration in hematological parameters such as red blood cells, white blood cells, hemoglobin, platelet, lymphocyte; antioxidant parameters, including malonaldehyde, superoxide dismutase, glutathione, glutathione peroxidase, catalase; cytokines viz., tumor necrosis factor-α (TNF-α), interleukin-1β (IL-1β), interleukin-6 (IL-6), interleukin-10 (IL-10), interleukin-18 (IL-18); inflammatory parameters such as cyclooxynase-2, inducible nitric oxide synthetase (iNOS), prostaglaindin, nuclear kappa B factor (NF-κB), C reactive protein and apoptosis parameters, including Bcl-2, Bax, and caspase-3. Fisetin treatment significantly (p < 0.001) altered the mRNA expression of TNF-α, IL-6, IL-1β, IL-10, Bax, Bcl-2, caspase-3, toll-like receptor 4, myeloid differentiation primary response protein 88, tumor necrosis factor receptor-associated factor 6, endothelial nitric oxide synthase, iNOS, NF-κB, inhibitor of kappaB kinase alpha, heme oxygenase-1, and nuclear factor erythroid 2-related factor 2. Fisetin treatment altered the hemorrhage, vascular proliferation, polymorphonuclear leukocyte, edema, vascular congestion, and apoptosis.
Conclusion
Fisetin ameliorated the ovary injury against ovarian ischemia-reperfusion via conquering TLR4-MyD88-TRAF6 signaling pathway.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- China Three Gorges University - The First College of Clinical Medical Science - Yichang - China.
- Yichang Central People's Hospital - Department of Obstetrics and Gynecology - Yichang - China.
- China Three Gorges University - Institute of Obstetrics and Gynecology - Yichang - China.
Förderung
- Natural Science Foundation of Hubei Province
Zitieren
APA
Gao, Q., Zhao, D., & He, W. (2025). Protective effects of fisetin on ovarian ischemia-reperfusion injury in rats via modulation of the TLR4-MyD88-TRAF6 signaling pathway. Acta Cirúrgica Brasileira, 40. https://doi.org/10.1590/acb405925
Vancouver
Gao Q, Zhao D, He W. Protective effects of fisetin on ovarian ischemia-reperfusion injury in rats via modulation of the TLR4-MyD88-TRAF6 signaling pathway. Acta Cirúrgica Brasileira. 2025;40. doi:10.1590/acb405925
BibTeX
@article{Gao2025,
author = {Gao, Qianqian and Zhao, Dan and He, Wencong},
title = {Protective effects of fisetin on ovarian ischemia-reperfusion injury in rats via modulation of the TLR4-MyD88-TRAF6 signaling pathway},
journal = {Acta Cirúrgica Brasileira},
year = {2025},
volume = {40},
doi = {10.1590/acb405925}
}
EUVIMED